| Similar Articles |
|---|
 |
BusinessWeek
May 20, 2010 |
Power to the Parasites After decades of fighting them, doctors are finding new uses for these biological parasitic freeloaders.   |
Salon.com
May 4, 2000
Susan McCarthy |
Eating germs Our semi-sterile lives may be too much of a good thing. Now scientists are inventing "dirty" therapies to remedy our dangerous cleanliness. Second of two parts. |
BusinessWeek
March 14, 2005
Arnst & Barrett |
Another Ailing Miracle Drug Biogen's troubles with Tysabri are a setback for immune-system treatments |
American Family Physician
August 15, 2003 |
Crohn's Disease What is Crohn's disease?... Who gets Crohn's disease?... How can my doctor tell if I have Crohn's disease?... How is Crohn's disease treated?... What can I expect after treatment?... etc. |
Salon.com
May 3, 2000
Susan McCarthy |
Talking dirty Bring on the germs. Too much cleanliness may be making some people sick. First of two parts. |
Salon.com
September 26, 2000
Jill Wolfson |
You're an excellent host Parasites can slip into your body, rewrite your DNA and, sometimes, change your mood. Science writer Carl Zimmer's new book, "Parasite Rex: Inside the Bizarre World of Nature's Most Dangerous Creatures," introduces readers to some of nature's most sinister characters... |
Popular Mechanics
December 4, 2009
Allie Townsend |
Can Parasites Heal as Well as Harm? Fringe Fact vs Fiction To sort through TV's "Fringe" theory of using "parasites as medicine," PM talks to molecular parasitologist Peter Hotez to get the real story on worms. |
Chemistry World
July 23, 2013
Sonja Hampel |
Antigenic sugars identified for Chagas disease Scientists have synthesised the combinations of sugars from the surface of the Chagas disease parasite that trigger the human immune response to it. This could help establish better diagnostic tests for the disease, and even a vaccine. |
The Motley Fool
January 16, 2008
Brian Lawler |
More Tysabri on the Way Biogen and Elan receive an additional approval for Tysabri. Investors, take note. |
The Motley Fool
November 21, 2007
Brian Lawler |
Elan and Biogen Denied Elan's multiple sclerosis treatment is denied a label expansion in Europe. Investors, take note. |
The Motley Fool
July 23, 2007
Brian Lawler |
A Setback for Elan and Biogen Elan and Biogen receive negative news about Tysabri. The EU medical authorities won't allow its use as a treatment for Crohn's disease. |
Salon.com
August 2, 2001
Ivan Oransky |
Human guinea pigs When people put their bodies on the line in medical trials, can they be sure that scientists aren't cutting corners or preoccupied with stock prices? |
Chemistry World
September 10, 2007
Lewis Brindley |
Taking the Sting Out of Malaria Scientists have identified sugar chains lining the mosquito's gut that the malaria parasite latches onto to infect the insect. |
Science News
February 19, 2005 |
Multiple Sclerosis In addition to explaining the autoimmune disorder in detail, this Web site offers links to sites that delve into treatments, current research, fundraising events, clinical trials of new drugs, and breaking news stories about MS. |
AskMen.com
Jacob Franek |
Parasitic Worms Who knew that parasitic worms were so common? Take the necessary precautions outlined here, and you'll most certainly be living worm-free. |
American Family Physician
August 15, 2003
Knutson et al. |
Management of Crohn's Disease -- A Practical Approach - Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract that affects up to 480,000 persons in the United States. Symptoms include abdominal pain, diarrhea, fever, malaise, and arthralgias, and cause considerable morbidity. |
Food Processing
August 2008 |
Caffeine might prevent MS Caffeine may help prevent multiple sclerosis (MS), an autoimmune disease affecting about 400,000 people in the U.S., according to a new animal study by researchers at the Oklahoma Medical Research Foundation |
American Family Physician
February 1, 2005 |
Inflammatory Bowel Disease A patient handout on the intestinal disease, its causes, diagnosis and treatment options. |
Chemistry World
March 22, 2011
Amaya Camara-Campos |
Microfluidics to diagnose sleeping sickness Jonas Tegenfeldt from the University of Lund developed a microfluidic device that separates the parasites in this disease from the blood cells using their shape, because parasites and red blood cells are very difficult to separate by size. |
The Motley Fool
June 18, 2007
Billy Fisher |
Elan Elevates Its Game New drug prospects push the Dublin-based biotech's shares to a new 52-week high. |
Nursing
November 2008
Michael W. Day |
Fight Back Against Inflammatory Bowel Disease It takes guts to live with Crohn's disease or ulcerative colitis, both of which can take a heavy toll on their victims. Find out how to help your patient tame the attacks. |
The Motley Fool
August 1, 2007
Brian Lawler |
Elan Gets a Vote of Confidence Elan receives some good news from an FDA advisory panel in the form of a recommendation to expand the use of Tysabri to treat Crohn's disease. |
HHMI Bulletin
May 2010
Kendall Powell |
Malaria's Weakness With different approaches, two HHMI researchers land on an enzyme critical to the malaria parasite's destructive ways. |
American Family Physician
November 15, 2001
Edward R. Feller |
Gynecologic Aspects of Crohn's Disease This article reviews the diverse gynecologic spectrum, protean manifestations and diagnostic difficulties of pelvic Crohn's disease... |
